Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients

OBJECTIVE: To evaluate the intraocular pressure (IOP)-lowering effect based on the number of ingredients and survival rate due to adverse reactions of brinzolamide (1%)/brimonidine (0.1%) fixed combination (BBFC). METHODS AND ANALYSIS: Among 424 patients newly administered BBFC from June 2020 to May...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Ryota, Terao, Etsuko, Dote, Saki, Shiraishi, Miku, Oogi, Satomi, Ueda, Kanae, Kimura, Yui, Nagata, Yuki, Nakakura, Shunsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Glaucoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809237/
https://www.ncbi.nlm.nih.gov/pubmed/36799023
http://dx.doi.org/10.1136/bmjophth-2022-001200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809237/
https://www.ncbi.nlm.nih.gov/pubmed/36799023
http://dx.doi.org/10.1136/bmjophth-2022-001200

Ejemplares similares